Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.21.2
Condensed Statements of Cash Flows - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2021
Cash Flows from Operating Activities:      
Net Income $ (11,074) $ (10,587,774) $ (3,056,609)
Adjustments to reconcile net income to net cash used in operating activities:      
Change in fair value of derivative warrant liabilities 0   (3,419,833)
Change in fair value of other derivative liabilities   5,048,594 5,048,594
Changes in operating assets and liabilities:      
Prepaid expenses 0   (74,219)
Accrued expenses 0   17,766
Accounts payable 0   (582,140)
Due to related parties 11,074   90,000
Dividend income 0   (18,127)
Net cash used in operating activities 0   (1,994,568)
Cash Flows from Financing Activities:      
Payment of offering costs 0   (70,679)
Proceeds of note payable from related parties 0   1,250,000
Net cash provided by financing activities 0   1,179,321
Net increase (decrease) in cash 0   (815,247)
Cash - Beginning of the period 0   1,044,177
Cash - End of the period 0 $ 228,930 $ 228,930
Supplemental disclosure of noncash investing and financing activities:      
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 25,000    
Deferred offering costs included in accrued expenses 294,140    
Deferred offering costs included in note payable $ 60,875